New survey data add to the evidence regarding the safe and effective route of administering both COVID-19 and flu vaccines simultaneously.
|Articles|May 3, 2004
It takes many approaches to trim specialty drug spending
Managed care organizations are implementing various methods to control their spiralling specialty pharmaceutical costs
Advertisement
Advertisement
Related to this article
This episode breaks down how PBMs conduct inventory audits, the sourcing and timing issues that trigger recoupments, and how pharmacies can prepare and push back.
In part 2 of our discussion with Kimberly Kue-Tsemo, PharmD, she addresses the emergence of technology and the nuances behind its actual capabilities.
In part 2, Allison Schneider, MPH, discusses PBM and 340B reform that could compound pharmacies’ burden amid ongoing Medicare drug price negotiations.
Researchers provide an update on the adverse events of special interest following patients who received 2024–2025 Pfizer-BioNTech COVID-19 vaccination.
Type 1 and type 2 diabetes reports emphasize areas where pharmacists can act now, including CGM, cardio-kidney therapies, and equitable patient access.
Kimberly Kue-Tsemo, PharmD, explores the current state of US pharmacy deserts amid ongoing reform, evolution in practice, and more.
Alyssa Eisenberg, PharmD, discusses key industry challenges and developments as community pharmacists continue to impact patient outcomes across the US.
Advertisement
Advertisement
Trending on Drug Topics
1
Updated Diabetes Consensus Shifts Focus from Glucose Control to Whole-Person Care
2
American Pharmacists Month: Pharmacy Deserts Growing in US Despite Rising Awareness
3
What the CLARITY Study Means for Counseling on Long-Acting HIV PrEP
4
Q&A: Overlapping PBM, 340B Reform Create Uncertainty for Pharmacies
5